Australia markets closed

Actinium Pharmaceuticals, Inc. (ATNM)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
8.96+0.21 (+2.40%)
At close: 04:00PM EDT
8.93 -0.03 (-0.33%)
After hours: 07:20PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts4455
Avg. Estimate-0.5-0.5-1.69-0.3
Low estimate-0.69-0.69-2.66-0.86
High estimate-0.35-0.34-1.331.21
Year ago EPS-0.58-0.49-1.83-1.69
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts4455
Avg. EstimateN/AN/AN/A64.53M
Low estimateN/AN/AN/A28.97M
High estimateN/AN/AN/A141.3M
Year ago salesN/A570k81kN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.48-0.53-0.54-0.52
Actual EPS-0.58-0.49-0.34-0.31
Difference-0.10.040.20.21
Surprise %-20.80%7.50%37.00%40.40%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.5-0.5-1.69-0.3
7 days ago-0.55-0.54-1.92-0.11
30 days ago-0.55-0.54-1.87-0.17
60 days ago-0.63-0.6-1.86-0.23
90 days ago-0.63-0.59-1.9-0.2
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days2231
Up last 30 days3331
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/A1
Growth estimatesATNMIndustrySector(s)S&P 500
Current qtr.13.80%N/AN/AN/A
Next qtr.-2.00%N/AN/AN/A
Current year7.70%N/AN/AN/A
Next year82.20%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A